• Consider NVIDIA (NVDA) as a buy candidate near $166, reflecting the speaker’s bullish view; no timeframe or valuation case was provided.
• Treat the AI-competition concerns around Microsoft (MSFT) and Adobe (ADBE) as a reason to reassess software exposure, not as a clear sell signal.
• Be cautious about Humacyte (HUMA): despite a good quarter and a rally, the speaker questioned its valuation against roughly $4 million in revenue and uncertain growth.
• Review concentration and updated fundamentals before acting on reported steep declines in Credo Technology (CRDO) and MKS Instruments (MKSI); the comments provide no recovery thesis.

NVIDIA (NVDA)

• The speaker said NVIDIA was around $166, up about 7%, and stated, “I think Nvidia’s buy now.”
• He also mentioned a statement from NVIDIA’s independent board members, but gave no details about its implications.

Takeaways

• The speaker expressed a bullish view and a direct buy opinion, but gave no investment timeframe or supporting valuation analysis. Treat the comment as a personal view, not a complete investment case.

Credo Technology (CRDO)

• Credo was described as the largest position in a portfolio being discussed.
• The stock had been “a little bit lousy” and had fallen more than 50% over the prior few months. The speaker speculated that the portfolio might no longer hold it, but did not know for sure.

Takeaways

• The reported drawdown is a reason to check current company and portfolio information rather than assume the position or outlook is unchanged. The transcript provides no explanation for the decline.

ASML (ASML)

• ASML, described in connection with lithography, was another larger portfolio holding.
• The speaker said it had also been a difficult investment, though its decline was not as severe as Credo’s.

Takeaways

• The comments point to weakness in a major semiconductor-equipment holding, but provide no specific outlook or valuation assessment. Consider the broader portfolio and business context before drawing conclusions from the comparison.

MKS Instruments (MKSI)

• MKS was described as a “gigantic holding,” with almost $1 billion invested in it in the portfolio being discussed.
• The stock was said to be down 50%.

Takeaways

• The reported decline and large position size make this a holding worth monitoring for concentration and updated company information. The transcript does not explain the fall or give a view on recovery.

Seagate Technology (STX)

• Seagate was described as another large holding in a technology-heavy portfolio, with almost $1 billion invested.
• No specific performance or outlook was provided.

Takeaways

• The discussion flags Seagate as a significant portfolio exposure, but offers no basis for a buy-or-sell conclusion. Investors may want to assess how it fits alongside other technology holdings.

Humacyte (HUMA)

• The speaker noted that HUMA’s stock was rallying and commented on possible revenue momentum, though the discussion of future quarters was unclear.
• He questioned a valuation of about $152 million for a company with $4 million in revenue, noting that it was not profitable and that revenue was not guaranteed to grow. He said it did not seem like a great deal.
• Later, he said HUMA had a good quarter, while reiterating frustration that people were not paying attention to the stock’s price.

Takeaways

• The speaker’s view was skeptical of the valuation relative to current revenue, despite acknowledging a good quarter and a rally. The transcript highlights profitability and uncertain revenue growth as concerns; investors should verify the figures and company updates.

Galaxy Digital (GLXY)

• The speaker said he was “very bullish in Galaxy” and joked that it was “going to go to the moon.”

Takeaways

• This was an explicitly bullish comment, but no reasoning, price target, or timeline was given. The transcript alone does not provide enough detail to evaluate the thesis.

Bitcoin (BTC)

• Bitcoin was mentioned at $72,000, with the speaker noting that it had “just” been at $80,000.
• No specific view on its future direction was stated.

Takeaways

• The price comparison highlights recent movement, but the transcript does not offer a Bitcoin investment thesis or recommendation.

Hims & Hers Health (HIMS)

• The speaker said it was “not easy to say” what would happen to Hims.

Takeaways

• The comment reflects uncertainty, not a bullish or bearish call. No company-specific drivers, price levels, or timeline were discussed.

Invivyd (IVVD)

• Someone asked whether the lack of data for IVVD was a bad sign. The speaker did not provide a clear answer or assessment.

Takeaways

• The transcript leaves the concern unresolved. It does not support a conclusion about the significance of the missing data.

AXT, Inc. (AXTI)

• AXTI was suggested as a stock to look at, and the speaker said it “might be an interesting one to look at.”
• No further analysis was provided.

Takeaways

• This was only a suggestion for further research, not a recommendation. The transcript offers no company details or investment rationale.

Marvell Technology (MRVL) and Coherent (COHR)

• Marvell and Coherent were mentioned together as companies to watch, with the speaker saying it would be interesting to see how they did.
• He also said he liked the CEO, without making clear which company he meant.

Takeaways

• The comments suggest interest, but not a defined bullish thesis. No price levels, catalysts, or risks were discussed.

CoreWeave (CRWV)

• CoreWeave was mentioned as having earnings coming up. The speaker called the event “not really exciting.”
• No earnings expectations or stock view were provided.

Takeaways

• Earnings were identified as a near-term event, but the transcript does not establish a specific catalyst or prediction. Investors may want to review the company’s results and guidance when available.

Anthropic, Microsoft (MSFT), and Adobe (ADBE)

• The speaker discussed Anthropic’s new tools, including “Claude Sheets,” and said they were probably not good for Microsoft or Adobe.
• He noted that Microsoft was “getting hit a couple ticks,” but did not provide a specific explanation or make a direct trade recommendation.
• More broadly, he expressed some concern about the future of software-as-a-service (SaaS). He suggested that AI could make software creation accessible to more people, shifting the importance toward “taste,” while noting that data can be difficult and expensive to obtain.

Takeaways

• The discussion raises a potential AI-competition risk for established software companies, especially if new tools make it easier to create alternatives. The speaker also pointed to data access and quality as a possible competitive moat, so the impact may differ by business.

Quantum Computing and Photonics (Theme)

• The speaker said an unnamed quantum company might perform best among quantum companies because it had moved toward photonics, which he viewed more favorably.
• Elsewhere, he dismissed quantum stocks broadly as “fake” or “fraudulent.” The transcript does not identify the company or explain the criticism.

Takeaways

• The comments are mixed: the speaker favored an unidentified photonics-related company while expressing broad skepticism about quantum stocks. Because no company was named and no evidence was discussed, this is not a basis for choosing a specific stock.

Cerebras (Private Company)

• Cerebras was mentioned by name, but no investment analysis or view was given.

Takeaways

• The transcript provides no actionable investment insight on Cerebras.